Author | Aziz Nazha, MD | OncLive

Author | Aziz Nazha, MD

Articles

Dr. Nazha on Mutational Model to Predict Response to Hypomethylating Agents in MDS

October 07, 2015

Video

Aziz Nazha, MD, hematologist, Leukemia Program at the Cleveland Clinic, Taussig Cancer Institute, discusses results of a mutational model to predict response to hypomethylating agents in myelodysplastic syndromes (MDS).

x